Literature DB >> 15557596

Enteropathogenic Escherichia coli infection triggers host phospholipid metabolism perturbations.

Y Wu1, B Lau, S Smith, K Troyan, D E Barnett Foster.   

Abstract

Enteropathogenic Escherichia coli (EPEC) specifically recognizes phosphatidylethanolamine (PE) on the outer leaflet of host epithelial cells. EPEC also induces apoptosis in epithelial cells, which results in increased levels of outer leaflet PE and increased bacterial binding. Consequently, it is of interest to investigate whether EPEC infection perturbs host cell phospholipid metabolism and whether the changes play a role in the apoptotic signaling. Our findings indicate that EPEC infection results in a significant increase in the epithelial cell PE level and a corresponding decrease in the phosphatidylcholine (PC) level. PE synthesis via both the de novo pathway and the serine decarboxylation pathway was enhanced, and de novo synthesis of phosphatidylcholine via CDP-choline was reduced. The changes were transitory, and the maximum change was noted after 4 to 5 h of infection. Addition of exogenous PC or CDP-choline to epithelial cells prior to infection abrogated EPEC-induced apoptosis, suggesting that EPEC infection inhibits the CTP-phosphocholine cytidylyltransferase step in PC synthesis, which is reportedly inhibited during nonmicrobially induced apoptosis. On the other hand, incorporation of exogenous PE by the host cells enhanced EPEC-induced apoptosis and necrosis without increasing bacterial adhesion. This is the first report that pathogen-induced apoptosis is associated with significant changes in PE and PC metabolism, and the results suggest that EPEC adhesion to a host membrane phospholipid plays a role in disruption of host phospholipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557596      PMCID: PMC529104          DOI: 10.1128/IAI.72.12.6764-6772.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

1.  Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment.

Authors:  D Barnett Foster; D Philpott; M Abul-Milh; M Huesca; P M Sherman; C A Lingwood
Journal:  Microb Pathog       Date:  1999-11       Impact factor: 3.738

2.  Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine.

Authors:  J S Haug; C M Goldner; E M Yazlovitskaya; P A Voziyan; G Melnykovych
Journal:  Biochim Biophys Acta       Date:  1994-08-11

Review 3.  Lipid translocation across the plasma membrane of mammalian cells.

Authors:  E M Bevers; P Comfurius; D W Dekkers; R F Zwaal
Journal:  Biochim Biophys Acta       Date:  1999-08-18

4.  Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli.

Authors:  A Ismaili; D J Philpott; M T Dytoc; P M Sherman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Lysophosphatidylcholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the CTP:phosphocholine cytidylyltransferase step.

Authors:  K P Boggs; C O Rock; S Jackowski
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

6.  Requirement of phosphatidylcholine for normal progression through the cell cycle in C3H/10T1/2 fibroblasts.

Authors:  F Tercé; H Brun; D E Vance
Journal:  J Lipid Res       Date:  1994-12       Impact factor: 5.922

7.  A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli.

Authors:  O G Gómez-Duarte; J B Kaper
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Expression of phosphatidylethanolamine N-methyltransferase-2 cannot compensate for an impaired CDP-choline pathway in mutant Chinese hamster ovary cells.

Authors:  M Houweling; Z Cui; D E Vance
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

9.  Phosphatidylethanolamine and sarcolemmal damage during ischemia or metabolic inhibition of heart myocytes.

Authors:  J A Post; J J Bijvelt; A J Verkleij
Journal:  Am J Physiol       Date:  1995-02

10.  Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine.

Authors:  K P Boggs; C O Rock; S Jackowski
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

View more
  8 in total

1.  N-acetyllactosamine conjugated to gold nanoparticles inhibits enteropathogenic Escherichia coli colonization of the epithelium in human intestinal biopsy specimens.

Authors:  Romney M Hyland; Paul Beck; George L Mulvey; Pavel I Kitov; Glen D Armstrong
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

2.  Phospholipids as implant coatings.

Authors:  R Willumeit; A Schuster; P Iliev; S Linser; F Feyerabend
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

3.  Direct injection of functional single-domain antibodies from E. coli into human cells.

Authors:  Ana Blanco-Toribio; Serge Muyldermans; Gad Frankel; Luis Ángel Fernández
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

4.  Ethanolamine: a signal to commence a host-associated lifestyle?

Authors:  Danielle A Garsin
Journal:  MBio       Date:  2012-07-03       Impact factor: 7.867

Review 5.  Ethanolamine Utilization in Bacteria.

Authors:  Karan Gautam Kaval; Danielle A Garsin
Journal:  MBio       Date:  2018-02-20       Impact factor: 7.867

Review 6.  Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract.

Authors:  Debora Barnett Foster
Journal:  Virulence       Date:  2013-04-03       Impact factor: 5.882

7.  Plasma metabolomic profiles and immune responses of piglets after weaning and challenge with E. coli.

Authors:  Sugiharto Sugiharto; Mette S Hedemann; Charlotte Lauridsen
Journal:  J Anim Sci Biotechnol       Date:  2014-03-14

Review 8.  Circulating Pro- and Anti-Inflammatory Metabolites and Its Potential Role in Rheumatoid Arthritis Pathogenesis.

Authors:  Roxana Coras; Jessica D Murillo-Saich; Monica Guma
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.